Login
$AVTX
$7.43 -$0.33 (4.25%) Live

Company Executives

Officer Age In this role Joined 2025 pay Source
Garry Neil Also a director
Chief Executive Officer
72 Not stated Not stated $3,807,581
Christopher Sullivan
Chief Financial Officer
42 Since 2022
4 years
2018 Not reported
Taylor Boyd
Chief Business Officer
37 Since 2025
1 year
2025 $3,219,751
Mittie Doyle
Chief Medical Officer
61 Since 2024
2 years
Not stated $1,780,557
Jennifer Riley
Chief Strategy Officer
51 Since 2025
1 year
Not stated Not reported
Paul Varki
Chief Legal Officer
53 Since 2024
2 years
Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 10, 2026 · updated by the 8-K of Jun 23, 2026

Directors
10
serving now
Independent
9 of 10
stated in the proxy
Average tenure
2.4 years
from year joined
CEO also chairs the board
No
Michael Heffernan
Director Age On board Independent Committees Other public boards 2025 pay Source
Michael Heffernan
61 2025
1 year
Independent None stated Biohaven (NYSE: BHVN) $509,578
Garry Neil
72 2022
4 years
Not independent None stated Celldex Therapeutics, Inc. (Nasdaq: CLDX) Paid as CEO
Rita Jain
63 2025
1 year
Independent
Audit
Celldex Therapeutics, Inc. (Nasdaq: CLDX) $177,579
Aaron Kantoff
40 2024
2 years
Independent None stated None stated $128,973
Gilla Kaplan, Ph.D.
78 2020
6 years
Independent None stated Tyra Biosciences, Inc. (Nasdaq: TYRA) $126,955
Kevin Lind
50 2025
1 year
Independent None stated None stated $456,488
Samantha Truex
55 2024
2 years
Independent None stated None stated $127,473
Ron Philip Joined Jun 23, 2026
- - Independent
Compensation Committee Science, Development and Commercial Advisory Committee
- -
Mitchell Chan Leaving at the meeting
Not stated Not stated Independent
Audit
None stated $133,991
Jonathan Goldman Leaving at the meeting
Not stated Not stated Independent None stated None stated $128,473

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

1 disclosed in the proxy filed Apr 10, 2026
Jennifer Riley
Chief Strategy Officer effective January 1, 2025; founder and sole member of Northbrook Consulting, LLC
Approximately $188,000
July 2024 to December 2024

Consulting services provided to the Company through Northbrook Consulting, LLC before Ms. Riley's appointment as Chief Strategy Officer; relationship ended December 31, 2024.

With Northbrook Consulting, LLC Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support